A case of keratoconus progression associated with the use of topical latanoprost.
Amano
Shiro
S
Department of Ophthalmology, University of Tokyo Graduate School of Medicine, Tokyo, Japan. amanos-tky@umin.ac.jp.
Nakai
Yoshiyuki
Y
Inoue Eye Hospital, Tokyo, Japan.
Ko
Akiko
A
Inoue Eye Hospital, Tokyo, Japan.
Inoue
Kenji
K
Inoue Eye Hospital, Tokyo, Japan.
Wakakura
Masato
M
Inoue Eye Hospital, Tokyo, Japan.
D000287:Administration, Topical; D000959:Antihypertensive Agents / Q000009:adverse effects*; D003315:Cornea / Q000187:drug effects* / Q000503:physiopathology; D019781:Corneal Topography; D018450:Disease Progression; D005902:Glaucoma, Open-Angle / Q000188:drug therapy; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D007640:Keratoconus / Q000139:chemically induced* / Q000503:physiopathology; D000077338:Latanoprost; D008297:Male; D008875:Middle Aged; D011461:Prostaglandins F, Synthetic / Q000009:adverse effects*; D014792:Visual Acuity; D014794:Visual Fields
D000959:Antihypertensive Agents; D011461:Prostaglandins F, Synthetic; D000077338:Latanoprost
Ophthalmology. 2005 Apr;112(4):654-9
15808258
Curr Eye Res. 2005 Oct;30(10):871-9
16251124
Invest Ophthalmol Vis Sci. 1997 Dec;38(13):2772-80
9418730
Invest Ophthalmol Vis Sci. 2003 Dec;44(12):5182-8
14638715
J Glaucoma. 2006 Jun;15(3):255-9
16778650